Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Alere San Diego, Inc.
WARNING LETTER
•Alere San Diego, Inc.•June 27, 2012

Alere San Diego, Inc. – FDA Warning Letter, Jun 27, 2012

Record Details

An FDA inspection of Alere San Diego, Inc. from March 12 to June 27, 2012, revealed that the firm's Triage brand cardiac marker and TOX Drug Screen devices are adulterated, as their manufacturing methods, facilities, or controls do not conform to the Quality System regulation (21 CFR Part 820). The firm's July 17, 2012, response to the FDA 483 observations was largely deemed inadequate.

Key violations include failures in process validation (21 CFR 820.75(a)), design output documentation (21 CFR 820.30(a)), control and disposition of nonconforming product (21 CFR 820.90(a), 820.90(b)), environmental controls (21 CFR 820.70(c)), use of statistical techniques (21 CFR 820.250(a)), document control (21 CFR 820.40), and maintenance of device history records (21 CFR 820.184). Specific issues ranged from inadequate oven specifications and assembly process validation to misaligned release specifications, improper handling of out-of-specification products, insufficient ESD controls, flawed stability testing, and the use of unapproved draft procedures.

The FDA requires prompt corrective actions, including systemic changes, with a written response within fifteen business days detailing steps taken, prevention plans, and a timetable for completion. Failure to comply may lead to regulatory actions such as seizure, injunction, civil money penalties, and impact on federal contracts, premarket approvals, and Certificates to Foreign Governments. The letter emphasizes that these violations may indicate broader issues in the firm's quality management systems.

Company
Alere San Diego, Inc.
Inspection date
June 27, 2012
Product type
Devices
Office
Department of Health and Human Services
People
  • Alonza E. Cruse (Director)
  • Blake Bevill (Director)
  • William S. Vitale (Compliance Officer)
View Company Profile

ID · 364d3d91-01b5-4362-af99-ffc63b8a4e23

Violation Codes10
21 U.S.C. 321(h)21 U.S.C. 351(h)21 CFR 82021 CFR 820.75(a)21 CFR 820.30(a)21 CFR 820.90(a)21 CFR 820.90(b)21 CFR 820.70(c)21 CFR 820.250(a)21 CFR 820.40

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Alere San Diego, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.